These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1273 related items for PubMed ID: 18655477

  • 1. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus].
    Serikova SIu, Kozlovskaia NL, Shilov EM.
    Ter Arkh; 2008; 80(6):52-8. PubMed ID: 18655477
    [Abstract] [Full Text] [Related]

  • 2. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
    Tektonidou MG, Sotsiou F, Nakopoulou L, Vlachoyiannopoulos PG, Moutsopoulos HM.
    Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
    [Abstract] [Full Text] [Related]

  • 3. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Figueredo MA, Rodriguez A, Ruiz-Yagüe M, Romero M, Fernandez-Cruz A, Gomez-de la Concha E, Patiño R.
    J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
    [Abstract] [Full Text] [Related]

  • 4. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
    Bruce IN.
    Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
    [Abstract] [Full Text] [Related]

  • 5. Pregnancy outcome in 396 pregnancies in patients with SLE in Saudi Arabia.
    Al Arfaj AS, Khalil N.
    Lupus; 2010 Dec; 19(14):1665-73. PubMed ID: 20947541
    [Abstract] [Full Text] [Related]

  • 6. [Subclinical and clinical manifestations of atherosclerosis in antiphospholipid syndrome].
    Reshetniak TM, Seredavkina nV, Mach ES, Aleksandrova EN, Novikov AA, Cherkasova MV, Nasonov EL.
    Ter Arkh; 2008 Dec; 80(10):60-7. PubMed ID: 19105418
    [Abstract] [Full Text] [Related]

  • 7. Correlation among WHO classes, histomorphologic patterns of glomerulonephritis and glomerular immune deposits in SLE.
    Ferluga D, Jerse M, Vizjak A, Hvala A, Rozman B, Kos-Golja M, Bren AF.
    Wien Klin Wochenschr; 2000 Aug 25; 112(15-16):692-701. PubMed ID: 11020959
    [Abstract] [Full Text] [Related]

  • 8. [Lipid profile in patients with systemic lupus erythematosus, with special focus on lipoprotein(a) in lupus nephritis].
    Kiss E, Fazekas B, Tarr T, Muszbek L, Zeher M, Szegedi G.
    Orv Hetil; 2004 Feb 01; 145(5):217-22. PubMed ID: 15024932
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
    Zhang CY, Lu LJ, Li FH, Li HL, Gu YY, Chen SL, Bao CD.
    J Clin Rheumatol; 2009 Apr 01; 15(3):111-6. PubMed ID: 19300290
    [Abstract] [Full Text] [Related]

  • 10. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
    Pradhan VD, Badakere SS, Bichile LS, Almeida AF.
    J Assoc Physicians India; 2004 Jul 01; 52():533-7. PubMed ID: 15645975
    [Abstract] [Full Text] [Related]

  • 11. Paediatric systemic lupus erythematosus: prognostic impact of antiphospholipid antibodies.
    Descloux E, Durieu I, Cochat P, Vital Durand D, Ninet J, Fabien N, Cimaz R.
    Rheumatology (Oxford); 2008 Feb 01; 47(2):183-7. PubMed ID: 18160418
    [Abstract] [Full Text] [Related]

  • 12. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N, Bertolaccini ML, Calabuig E, Hughes GR, Khamashta MA.
    Ann Rheum Dis; 2005 Mar 01; 64(3):444-8. PubMed ID: 15286009
    [Abstract] [Full Text] [Related]

  • 13. [Clinical and morphological characteristics of lupus nephritis in systemic lupus erythematosus with antiphospholipid syndrome].
    Kozlovskaia NL, Shilov EM, Meteleva NA, Varshavskiĭ VA, Miroshnichenko NG, Samokishina NA, Serova AG, Nesterova SG.
    Ter Arkh; 2006 Mar 01; 78(5):21-31. PubMed ID: 16889045
    [Abstract] [Full Text] [Related]

  • 14. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
    Cheunsuchon B, Rungkaew P, Chawanasuntorapoj R, Pattaragarn A, Parichatikanond P.
    Nephrology (Carlton); 2007 Oct 01; 12(5):474-80. PubMed ID: 17803471
    [Abstract] [Full Text] [Related]

  • 15. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis.
    Cohen D, Koopmans M, Kremer Hovinga IC, Berger SP, Roos van Groningen M, Steup-Beekman GM, de Heer E, Bruijn JA, Bajema IM.
    Arthritis Rheum; 2008 Aug 01; 58(8):2460-9. PubMed ID: 18668574
    [Abstract] [Full Text] [Related]

  • 16. Role of lipids in the progression of renal disease in systemic lupus erythematosus patients.
    Luzar B, Ferluga D.
    Wien Klin Wochenschr; 2000 Aug 25; 112(15-16):716-21. PubMed ID: 11020963
    [Abstract] [Full Text] [Related]

  • 17. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies.
    Tektonidou MG, Laskari K, Panagiotakos DB, Moutsopoulos HM.
    Arthritis Rheum; 2009 Jan 15; 61(1):29-36. PubMed ID: 19116963
    [Abstract] [Full Text] [Related]

  • 18. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
    Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE.
    Ann Rheum Dis; 2008 Mar 15; 67(3):395-401. PubMed ID: 17644539
    [Abstract] [Full Text] [Related]

  • 19. Ethnic, clinical and immunological factors in systemic lupus erythematosus and the development of lupus nephritis: results from a multi-ethnic New Zealand cohort.
    Burling F, Ng J, Thein H, Ly J, Marshall MR, Gow P.
    Lupus; 2007 Mar 15; 16(10):830-7. PubMed ID: 17895308
    [Abstract] [Full Text] [Related]

  • 20. Nephropathy associated with antiphospholipid antibodies in patients with systemic lupus erythematosus.
    Silvariño R, Sant F, Espinosa G, Pons-Estel G, Solé M, Cervera R, Arrizabalaga P.
    Lupus; 2011 Jun 15; 20(7):721-9. PubMed ID: 21486929
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 64.